Evidence map›Paper›PMID 40534558›Full record

ArticleStroke2025

Investigation of Poststroke Depression Following a Nucleus Accumbens Infarct in Mice.

Jonathan Bouchard, Béatrice Daigle, Adeline Collignon, Vincent St-Arnault, Luisa Bandeira Binder, Laura Menegatti Bevilacqua, Véronique Rioux, Laurence Dion-Albert, Manon Lebel, Martin Lévesque and 2 more

Abstract read
In one paragraph

Article in Stroke, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Jonathan Bouchard *Faculty of Medicine, Department of Psychiatry and Neuroscience and CERVO Brain Research Center (J.B., B.D., A.C., L.B.B., L.M.B., V.R., L.D.-A., M. Lebel, M. Lévesque, C.M.), Université Laval, Quebec, QC, Canada.
Béatrice Daigle *Faculty of Medicine, Department of Psychiatry and Neuroscience and CERVO Brain Research Center (J.B., B.D., A.C., L.B.B., L.M.B., V.R., L.D.-A., M. Lebel, M. Lévesque, C.M.), Université Laval, Quebec, QC, Canada.ORCID 0000-0002-2953-9515
Adeline CollignonFaculty of Medicine, Department of Psychiatry and Neuroscience and CERVO Brain Research Center (J.B., B.D., A.C., L.B.B., L.M.B., V.R., L.D.-A., M. Lebel, M. Lévesque, C.M.), Université Laval, Quebec, QC, Canada.ORCID 0009-0005-5086-5648
Vincent St-ArnaultFaculty of Sciences and Engineering, Department of Physics, Physic Engineering and Optics and CERVO Brain Research Center (V.S.-A., M.D.), Université Laval, Quebec, QC, Canada.
Luisa Bandeira BinderFaculty of Medicine, Department of Psychiatry and Neuroscience and CERVO Brain Research Center (J.B., B.D., A.C., L.B.B., L.M.B., V.R., L.D.-A., M. Lebel, M. Lévesque, C.M.), Université Laval, Quebec, QC, Canada.ORCID 0000-0003-2372-8689
Laura Menegatti BevilacquaFaculty of Medicine, Department of Psychiatry and Neuroscience and CERVO Brain Research Center (J.B., B.D., A.C., L.B.B., L.M.B., V.R., L.D.-A., M. Lebel, M. Lévesque, C.M.), Université Laval, Quebec, QC, Canada.
Véronique RiouxFaculty of Medicine, Department of Psychiatry and Neuroscience and CERVO Brain Research Center (J.B., B.D., A.C., L.B.B., L.M.B., V.R., L.D.-A., M. Lebel, M. Lévesque, C.M.), Université Laval, Quebec, QC, Canada.ORCID 0009-0007-7108-2268
Laurence Dion-AlbertFaculty of Medicine, Department of Psychiatry and Neuroscience and CERVO Brain Research Center (J.B., B.D., A.C., L.B.B., L.M.B., V.R., L.D.-A., M. Lebel, M. Lévesque, C.M.), Université Laval, Quebec, QC, Canada.ORCID 0000-0002-7051-6390
Manon LebelFaculty of Medicine, Department of Psychiatry and Neuroscience and CERVO Brain Research Center (J.B., B.D., A.C., L.B.B., L.M.B., V.R., L.D.-A., M. Lebel, M. Lévesque, C.M.), Université Laval, Quebec, QC, Canada.ORCID 0000-0003-1649-1214
Martin LévesqueFaculty of Medicine, Department of Psychiatry and Neuroscience and CERVO Brain Research Center (J.B., B.D., A.C., L.B.B., L.M.B., V.R., L.D.-A., M. Lebel, M. Lévesque, C.M.), Université Laval, Quebec, QC, Canada.ORCID 0000-0002-1547-3746
Michèle DesjardinsFaculty of Sciences and Engineering, Department of Physics, Physic Engineering and Optics and CERVO Brain Research Center (V.S.-A., M.D.), Université Laval, Quebec, QC, Canada.ORCID 0000-0003-1112-1628
Caroline MénardFaculty of Medicine, Department of Psychiatry and Neuroscience and CERVO Brain Research Center (J.B., B.D., A.C., L.B.B., L.M.B., V.R., L.D.-A., M. Lebel, M. Lévesque, C.M.), Université Laval, Quebec, QC, Canada.ORCID 0000-0001-8202-7378

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPoststroke depression (PSD) affects ≈33% of individuals 1 year after a stroke. Blood-brain barrier (BBB) dysfunction in the nucleus accumbens (NAc), a hub for emotional processing, reward, and mood regulation, has been linked to stress-induced depressive-like behaviors in male mice. Neurovascular alterations were also observed in postmortem tissue samples from men with a diagnosis of major depression. Thus, we aimed to investigate if BBB changes in the NAc could contribute to PSD pathophysiology.

methodsStereotaxic injection of ET-1 (endothelin-1), a potent vasoconstrictor, was performed in the NAc of male mice to create a focal brain stroke, and then, infarct size and localization were assessed and quantified. We subsequently evaluated transcriptomic and morphological effects of the infarct on BBB-related genes and cells in the NAc, particularly those known to be altered after stress exposure in mice or human depression. BBB integrity was assessed with a dextran dye, and magnetic resonance imaging scans were conducted before versus after the injection of Gadovist, a contrast agent. Last, a battery of behavioral tests related to depressive- and anxiety-like behaviors was performed to determine if an infarct in the NAc is sufficient to induce a PSD-like phenotype.

resultsFollowing ET-1 injection, ≈50% of the total lesion was observed in the NAc leading to BBB hyperpermeability in this brain area. BBB gene expression was impacted by ET-1, and also surgery alone and profiles were differentially regulated throughout time up to 14 days. Gliosis in the NAc was observed with increased reactivity of astrocytes and microglia. The effect of ET-1 on PSD-like symptoms was limited. However, body weight, sociability, and activity were affected by surgery with a more pronounced impact of ET-1 on social interactions compared with naive animals.

conclusionsWhile no clear PSD phenotype was observed following an ET-1-induced stroke in the NAc of male mice, our study shed light on the technical complexity of focal lesions in deep brain structures, an understudied phenomenon occurring in humans. We provide technical insights for the development of a mouse model of deep brain lesions, characterize its impact at molecular, cellular, and behavioral levels, and highlight the need to control for vascular alterations when performing stroke surgeries.

Indexed as

Blood-Brain BarrierDepressionNucleus AccumbensStrokeAnimalsBehavior, AnimalDisease Models, AnimalEndothelin-1MaleMiceMice, Inbred C57BLEndothelin-1behaviorblood-brain barrierdepressiondisease models, animalgene expression

Identifiers

PMID40534558
PMCPMC12372732

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.